financetom
Business
financetom
/
Business
/
Home Depot's Q2 In Line With Expectations Amid Weather Disruptions and High Interest Rates, Truist Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Home Depot's Q2 In Line With Expectations Amid Weather Disruptions and High Interest Rates, Truist Says
Aug 20, 2025 3:56 AM

03:26 PM EDT, 08/19/2025 (MT Newswires) -- Home Depot's ( HD ) Q2 performance was in line with expectations, with total sales within 10 basis points of estimate, despite weather disruptions and high interest rates, Truist said in a note Tuesday.

Truist card data showed sales picked up during the quarter, especially in the last six weeks, following a slow start likely caused by poor weather, the investment firm said.

The quarter marked Home Depot's ( HD ) third straight period of positive US comps, which supports a gradual shift away from expectations based on the prior low-rate environment, Truist analysts noted.

Gross margins were 33.4%, flat year over year and slightly above estimates, while adjusted earnings before interest and taxes margins came in at 14.8%, narrowly missing the 14.9% estimate, according to the note.

Adjusted EPS was $4.68, just below the $4.70 estimate, with EBIT roughly matching forecasts at $6.7 billion, Truist said.

Home Depot ( HD ) reaffirmed its full-year guidance, including 2.8% total sales growth, 1% comp growth, 13.4% adjusted EBIT margin, and $14.95 in adjusted EPS, Truist noted.

Truist maintained a buy rating for Home Depot ( HD ) with a $433 price target.

Shares of the company were up over 3% in recent trading.

Price: 406.35, Change: +11.65, Percent Change: +2.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pulse Biosciences Q3  net loss widens
Pulse Biosciences Q3  net loss widens
Nov 5, 2025
Overview * Pulse Biosciences Q3 2025 revenue was $86 thousand, marking limited market release start * GAAP net loss for Q3 widened to $19.4 mln from $12.7 mln last year * Increased expenses due to expanding organization for clinical trials and commercialization Result Drivers * LIMITED MARKET RELEASE - Generated $86 thousand in revenue from the limited market release of...
Pfizer preparing to raise its bid for Metsera, WSJ reports
Pfizer preparing to raise its bid for Metsera, WSJ reports
Nov 5, 2025
(Reuters) -Pfizer ( PFE ) is preparing to sweeten its offer again for Metsera ( MTSR ), the Wall Street Journal reported on Wednesday, citing people familiar with the matter. (Reporting by Kamal Choudhury in Bengaluru; Editing by Sriraj Kalluvila) ...
Klaviyo Q3 revenue up 32%, beats estimates
Klaviyo Q3 revenue up 32%, beats estimates
Nov 5, 2025
Overview * Klaviyo ( KVYO ) Q3 revenue grows 32% yr/yr to $310.9 mln, beating analyst expectations * Company raises FY25 revenue guidance to $1.215 bln-$1.219 bln, indicating 30% growth * Klaviyo ( KVYO ) reports net loss for Q3 despite strong revenue growth Outlook * Klaviyo ( KVYO ) raises FY25 revenue guidance to $1.215 bln to $1.219 bln...
Top potash producer Nutrien beats third-quarter profit estimates
Top potash producer Nutrien beats third-quarter profit estimates
Nov 5, 2025
Nov 5 (Reuters) - Nutrien ( NTR ) beat analysts' expectations for third-quarter profit on Wednesday, as the world's top potash producer benefited from higher sales volumes. The Saskatoon, Canada-based firm posted an adjusted profit of 97 cents per share for the three months ended September 30, compared with analysts' average estimate of 95 cents per share, according to data...
Copyright 2023-2026 - www.financetom.com All Rights Reserved